For Quick Alerts
For Daily Alerts

DR Reddy’s Shares Gain On Receiving EIR From The US FDA


Shares in Dr Reddy's gained after the company said it has received Establishment Inspection Report for its Formulations Manufacturing Plant - 3 at Bachupally, Hyderabad.

DR Reddy’s Shares Gain On Receiving EIR From The US FDA

"Further to our intimation dated February 28, 2020 with regard to the audit of our Formulations Manufacturing Plant - 3 at Bachupally, Hyderabad, we would like to inform you that we have received the Establishment Inspection Report (EIR) from US FDA, for the above-referred facility, indicating closure of the audit," the company said in a statement to the exchanges.

The shares of the company were last trading at Rs 3,744, up 2 per cent in trade. The stock has hit a 52-week high of Rs 4142.

Read more about: reddy fda
Story first published: Wednesday, May 20, 2020, 10:10 [IST]
Company Search
Get Instant News Updates
Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more